DDX47 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.510800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.163700E-02
Normal-vs-Stage2
8.165000E-01
Normal-vs-Stage3
5.713200E-01
Normal-vs-Stage4
3.643000E-01
Stage1-vs-Stage2
1.851710E-02
Stage1-vs-Stage3
8.773400E-01
Stage1-vs-Stage4
4.560900E-03
Stage2-vs-Stage3
5.490600E-01
Stage2-vs-Stage4
4.593200E-01
Stage3-vs-Stage4
3.215600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.811400E-01
Normal-vs-AfricanAmerican
5.788400E-01
Normal-vs-Asian
4.877600E-01
Caucasian-vs-AfricanAmerican
9.382800E-01
Caucasian-vs-Asian
4.430600E-01
AfricanAmerican-vs-Asian
6.259600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.743800E-01
Normal-vs-Female
7.385400E-01
Male-vs-Female
7.990600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.201600E-02
Normal-vs-Age(41-60Yrs)
8.176800E-01
Normal-vs-Age(61-80Yrs)
3.994800E-01
Normal-vs-Age(81-100Yrs)
9.230000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.798200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.350600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.055400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.599500E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.836200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.370300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.047600E-01
Normal-vs-Daily Drinker
5.048600E-01
Normal-vs-Weekly Drinker
5.586400E-01
Normal-vs-Occasional Drinker
5.661000E-01
Normal-vs-Social Drinker
9.735600E-01
Non Drinker-vs-Daily Drinker
7.996200E-01
Non Drinker-vs-Weekly Drinker
9.963600E-01
Non Drinker-vs-Occasional Drinker
3.039600E-02
Non Drinker-vs-Social Drinker
5.490600E-01
Daily Drinker-vs-Weekly Drinker
8.266200E-01
Daily Drinker-vs-Occasional Drinker
2.497700E-02
Daily Drinker-vs-Social Drinker
4.590800E-01
Weekly Drinker-vs-Occasional Drinker
6.822100E-02
Weekly Drinker-vs-Social Drinker
5.637400E-01
Occasional Drinker-vs-Social Drinker
3.578600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.602160E-01
Normal-vs-Grade 2
6.963700E-02
Normal-vs-Grade 3
1.137760E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.449600E-02
Grade 1-vs-Grade 3
3.756900E-03
Grade 1-vs-Grade 4
1.602160E-01
Grade 2-vs-Grade 3
5.078300E-02
Grade 2-vs-Grade 4
6.963700E-02
Grade 3-vs-Grade 4
1.137760E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.149400E-01
Normal-vs-NonDiabetic
8.338000E-01
Diabetic-vs-NonDiabetic
2.995000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.003800E-01
Normal-vs-NoPancreatitis
7.320200E-01
Pancreatitis-vs-NoPancreatitis
6.311600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.287600E-01
Normal-vs-N1
7.687400E-01
N0-vs-N1
7.807800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.726400E-01
Normal-vs-TP53-NonMutant
4.615400E-01
TP53-Mutant-vs-TP53-NonMutant
5.92999999999844E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
